a-Cellular Matrix Hydrogel (ECMH) that will culmin
Post# of 36537
(Total Views: 110)
Posted On: 01/03/2019 9:50:43 AM
a-Cellular Matrix Hydrogel (ECMH) that will culminate in FDA submission and approval. The equity line enables Generex to manage its financials by making payments to our subsidiaries based on value-driven milestones rather than through immediate shareholder dilution.
Read More: https://investorshangout.com/post/view?id=530...z5bYXjVp4G
Non-dilutive financing, at least for the short-term. How long have we been waiting to see that?
Read More: https://investorshangout.com/post/view?id=530...z5bYXjVp4G
Non-dilutive financing, at least for the short-term. How long have we been waiting to see that?
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼